Page last updated: 2024-09-03

ginsenoside rh2 and Angiogenesis, Pathologic

ginsenoside rh2 has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, L; Gao, K; Li, P; Li, Z; Liu, J; Liu, S; Qi, Y; Qi, Z; Shao, Z; Sun, Y1
Ding, Y; Gao, Y; Yi, X; Zhou, J1

Other Studies

2 other study(ies) available for ginsenoside rh2 and Angiogenesis, Pathologic

ArticleYear
Immunomodulatory Effects of (24R)-Pseudo-Ginsenoside HQ and (24S)-Pseudo-Ginsenoside HQ on Cyclophosphamide-Induced Immunosuppression and Their Anti-Tumor Effects Study.
    International journal of molecular sciences, 2019, Feb-15, Volume: 20, Issue:4

    Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Cyclophosphamide; Ginsenosides; Humans; Immunity, Innate; Immunologic Factors; Mice; Neovascularization, Pathologic; Phagocytosis; Signal Transduction; Spleen; T-Lymphocytes

2019
Ginsenoside Rh2 Suppresses Neovascularization in Xenograft Psoriasis Model.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 36, Issue:3

    Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Gene Expression; Ginsenosides; Heterografts; Humans; Mice; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Psoriasis; Skin; T-Lymphocytes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2015